Gynecologic, Ovarian, and Cervical Cancer

GYNECOLOGIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Oral Contraceptives Found to Protect Against Ovarian and Endometrial Cancer for up to 35 Years After Discontinuation

Investigators of the observational study sought to clarify the time-dependent effects between long-term oral contraceptive use and risk for breast, ovarian, and endometrial cancer risk.
American Cancer Society Updates Cervical Cancer Screening Guidelines

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.
Radiotherapy for Cervical Cancer: An Introduction to ASTRO’s Clinical Practice Guideline

The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings.
Clinical Utility of Deep Phenotyping and Whole-Genome Risk Assessment in Early Cancer Detection and Precision Oncology

State-of-the-art advanced imaging coupled with whole-genome sequencing shows utility in early cancer detection and cancer-associated pathogenic variant detection.
Preclinical Work on Red Blood Cell-Based Therapies in HPV-Positive Solid Tumors Provides Rationale for Clinical Trials in Humans

A microfluidics platform for engineering activated antigen carrier immunotherapies from red blood cells showed promising preliminary results in a mouse model.

GYNECOLOGIC CANCER NEWS

Oral bisphosphonates may greatly reduce the risk of endometrial cancer.

Intrauterine Levonorgestrel Showed Activity in Endometrial Adenocarcinoma

April 22, 2021

Although most female patients regain fertility after CHOP-like chemotherapy for aggressive lymphoma,

Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer

April 19, 2021

Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer

April 14, 2021

Improved Overall Survival With Cemiplimab in Cervical Cancer Trial

March 16, 2021

During a recent conference on quality of life in patients with cancer, FDA-affiliated researchers debunked a notion about biases — but raised some concerns about PROs.

Most Patients With Breast, Ovarian Cancer Do Not Undergo Genetic Testing

March 1, 2021

Next post in Gynecologic Cancer

Although most female patients regain fertility after CHOP-like chemotherapy for aggressive lymphoma,

Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer